Register Login
Register to leave comments
  • News bot Aug. 7, 2026, 10:31 p.m.

    🔍 Garcia Marino (Executive)

    Company: Dianthus Therapeutics, Inc. /DE/ (DNTH)

    Report Date: 2026-08-07

    Transaction Summary:

    • Total transactions: 11
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 166,000
    • Total shares sold: 332,000

    Detailed Transactions and Holdings:

    • Acquired 40,000 shares of Common Stock at $8.44 per share (Direct)
      Date: 2026-08-07 | Code: M | equity_swap_involved: false | shares_owned_after: 105,292.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 126,000 shares of Common Stock at $8.44 per share (Direct)
      Date: 2026-08-07 | Code: M | equity_swap_involved: false | shares_owned_after: 231,292.00 | transaction_form_type: 4
    • Sold 10,384 shares of Common Stock at $107.49 per share (Direct)
      Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 220,908.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 23,907 shares of Common Stock at $108.05 per share (Direct)
      Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 197,001.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 2,373 shares of Common Stock at $109.1 per share (Direct)
      Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 194,628.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 2,536 shares of Common Stock at $110.02 per share (Direct)
      Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 192,092.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 800 shares of Common Stock at $110.76 per share (Direct)
      Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 191,292.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 104,091 shares of Common Stock at $107.96 per share (Direct)
      Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 87,102.00 | transaction_form_type: 4 | Footnotes: F6
    • Sold 21,909 shares of Common Stock at $108.72 per share (Direct)
      Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 65,292.00 | transaction_form_type: 4 | Footnotes: F7
    • Sold 40,000 shares of Stock Option (Right to Buy) at $8.44 per share (Derivative)
      Date: 2026-08-07 | Code: M | Expires: 2032-06-06 | equity_swap_involved: false | shares_owned_after: 286,004.00 | transaction_form_type: 4 | Footnotes: F1, F8
    • Sold 126,000 shares of Stock Option (Right to Buy) at $8.44 per share (Derivative)
      Date: 2026-08-07 | Code: M | Expires: 2032-06-06 | equity_swap_involved: false | shares_owned_after: 160,004.00 | transaction_form_type: 4 | Footnotes: F8

    Footnotes:

    • F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026.
    • F2: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.68 to $107.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F3: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.68 to $108.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F4: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.74 to $109.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F5: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.75 to $110.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.52 to $108.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
    • F7: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.57 to $108.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F8: The shares of common stock underlying this stock option award vested as to 25% of the shares on November 1, 2022, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Search

News categories